Navigation Links
Hemostemix Meets with Newly Formed Clinical Trial Steering Committee
Date:12/20/2013

ity of Witten in Germany. Dr. Burchardt has over 20 years of academic and industry experience in the areas of cell therapy, hematology, inflammation and cardiovascular diseases. He has designed and completed over 40 clinical trials with cell therapy and biological products in North America, Europe and other regions of the world, resulting in several marketing authorizations- As Vice President, Elmar initiated and successfully completed Aastrom Bioscience’s US-based phase II clinical cell therapy trials in Critical Limb Ischemia and Dilated Cardiomyopathy.

  •     York N. Hsiang, MB. ChB, MHS., FRCSC, is Professor of Vascular Surgery at the University of British Columbia and Consultant Surgeon at the Vancouver General Hospital, Vancouver, B.C. He has been the Professor of Surgery at the University of British Columbia in the Division of Vascular Surgery since July 2000. Dr. Hsiang has Specialty Board Qualifications in General Surgery (FRCSC 1986), Special Competence in Vascular Surgery (1987), and MHSc. (Clinical Epidemiology and Biostatistics, UBC, 1987-88).
  •     Thomas F. Lindsay, MD is Professor of Surgery and Chair of the Division of Vascular Surgery at the University of Toronto. He is head of the Division of Vascular Surgery within the Peter Monk Cardiac Center at University Health Network and Chair of the Royal College of Physicians and Surgeon of Canada Vascular Surgery Specialty Committee.
  •     Mark Jay Zucker, MD, JD, FACC, FAC is the Company’s Scientific Advisory Board representative on the clinical steering committee. Dr. Zucker is Director of the Harvey and Georgina Weinstein National Heart Transplant Center at Newark Beth Israel Medical Center and Clinical Professor of Medicine at the University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, N.J. He has been a principal or co-investigator on more than 40 trials includi
    '/>"/>

  • Source: PRWeb
    Copyright©2012 Vocus, Inc.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Hemostemix Hosts Cell Therapy Industry Seminar
    2. Hemostemix Announces Formation of Scientific Advisory Board
    3. Hemostemix Announces US Patent Allowance
    4. The Hemostemix Group of Companies Provides Corporate Strategy Update
    5. What can happen when graphene meets a semiconductor
    6. Discovery Meets Recovery in New Cedars-Sinai’s Advanced Health Sciences Pavilion Designed by HOK
    7. Marken Meets Critical Demand For In Vitro Lab Shipments
    8. SPIE ‘gold’ open access program meets new needs of UK authors -- and others
    9. Origami meets chemistry in scholarly video-article
    10. Veridiams Training Program Wins Accolades and Awards- Meets Skilled Labor Challenge Head On
    11. Human Genome Decoder and Artificial Life Creator, J. Craig Venter to Speak at "The Atlantic Meets the Pacific"
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/26/2014)... , Aug. 26, 2014   Loveland Products, ... provider of high-performance crop input products and proprietary ... that the company has acquired a controlling interest ... agricultural biotechnology company delivering biochemical-based products for efficient ... Loveland Products, fastest growing plant nutrition brands, Accomplish ...
    (Date:8/26/2014)... NEW YORK , Aug. 26, 2014  That,s ... life science markets, today announced the formation of a ... strategic content development. The expanded team will combine current ... messaging areas at That,s Nice. ... Strategic Content to lead the team. Tiene was previously ...
    (Date:8/26/2014)... 26, 2014 InstantGMP, Inc., the only ... a new pricing structure with increased user accounts to ... and 21 CFR Part 11 requirements. , “We want ... way we can” said Rick Soltero, President of InstantGMP. ... users allowed customers to have separate accounts for multiple ...
    (Date:8/26/2014)... MA (PRWEB) August 26, 2014 ... solutions, today announced the release of Transform for ... for Electronic Data Capture (EDC) product line. It ... XClinical, and allows integration with MARVIN, the EDC ... as reducing study setup time, by allowing instantaneous ...
    Breaking Biology Technology:Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 2Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 3Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3Introducing Transform for MARVIN: Providing Further Flexibility for CROs and Sponsors in Partnership with XClinical 2
    ... of Panzem(R) NCD and Avastin(R) May Slow ... EntreMed, Inc.,(Nasdaq: ENMD ), a ... of cancer and inflammatory diseases, today,announced the ... 2 multi-center,study combining Panzem(R) NCD with Avastin(R) ...
    ... YORK, Jan. 28 The Medefield Group, the ... market research, consulting,and communications companies, is pleased to ... After another year of unprecedented growth,attributed to Medefield,s ... client base, the company is adding to its,ever-growing ...
    ... (Nasdaq: MNKD ), focused on discovering, developing and,commercializing ... present at the Wachovia Healthcare Conference on January 30, ... Boston, MA., Interested parties can access a link ... Investor Relations section of the Company,s website at, http://www.mannkindcorp.com ...
    Cached Biology Technology:EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 2EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 3EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 4Medefield Announces New Appointments to North American Business Unit 2
    (Date:8/26/2014)... tent over a colony of harmful bacteria, biofilms ... Microorganisms protected in a biofilm pose a significant ... recalcitrance to treatment, and biofilm-protected bacteria account for ... humans and are 50 to 1,000 times more ... "In essence, we may have stumbled onto a ...
    (Date:8/26/2014)... obtaining an unprecedented view of a type of ... of neurological illnesses, including Alzheimer,s disease, Parkinson,s disease, ... stroke. , The team of biologists at Cold ... Energy,s Advanced Photon Source at Argonne National Laboratory ... NMDA (N-methyl, D-aspartate) receptor should serve as template ...
    (Date:8/26/2014)... New Zealand endemic tree has for the last 31 years ... Australian shrubs and small trees. A New Zealand botanist has ... astonishing cryptic diversity behind what was long considered a single ... journal PhytoKeys . , Known to botanists ... the many discoveries made in the north-western South Island of ...
    Breaking Biology News(10 mins):Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 2Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 3And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 2And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 3
    ... than 10 percent each year from 2010 to 2050 ... fuels, but this is an unsustainable prospect. According to ... Governance, Economy and Ecology such a large growth rate ... otherwise each new power plant will simply cannibalize the ...
    ... (March 4, 2008) A unique dietary supplement called ... following experimental stroke. A nutritional supplement product, NutraStem also ... blueberry, green tea, vitamin D3 and carnosine extracts- a ... protecting against brain damage. Stroke is the third ...
    ... Research Council (BBSRC) funded scientists at the University of ... process of carbon dioxide fixation in plants. ... Proceedings of the National Academy of Sciences, increases our ... crop improvement and fourth generation biofuels. The mechanism, which ...
    Cached Biology News:Nuclear cannibals 2Blueberry and green tea containing supplement protects against stroke damage 2Scientists uncover a novel mechanism that regulates carbon dioxide fixation in plants 2
    ... Serum • Beagle serum is collected from ... year of age Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium ... Alsevers N-05: ACD N-07: ...
    MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein...
    MOUSE ANTI BOVINE TROPONIN I...
    Ready-to-use; 40mg/ml X-Gal and 32mg/ml IPTG...
    Biology Products: